Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of Phreesia Inc (NYSE: PHR) was $24.84 for the day, down -4.90% from the previous closing price of $26.12. In other words, the price has decreased by -$4.90 from its previous closing price. On the day, 0.55 million shares were traded. PHR stock price reached its highest trading level at $25.28 during the session, while it also had its lowest trading level at $24.46.
Ratios:
Our analysis of PHR’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 17.33 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 62.07. For the most recent quarter (mrq), Quick Ratio is recorded 1.78 and its Current Ratio is at 1.78. In the meantime, Its Debt-to-Equity ratio is 0.07 whereas as Long-Term Debt/Eq ratio is at 0.03.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on January 08, 2025, Upgraded its rating to Outperform and sets its target price to $32 from $24 previously.
On February 26, 2024, Truist started tracking the stock assigning a Buy rating and target price of $35.
DA Davidson Upgraded its Neutral to Buy on January 17, 2024, whereas the target price for the stock was revised from $30 to $32.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Mar 26 ’25 when Gandhi Balaji sold 1,827 shares for $27.46 per share. The transaction valued at 50,177 led to the insider holds 103,591 shares of the business.
Gandhi Balaji bought 1,827 shares of PHR for $50,177 on Mar 26 ’25. On Mar 19 ’25, another insider, Linetsky David, who serves as the SVP, Life Sciences of the company, sold 88 shares for $27.88 each. As a result, the insider received 2,454 and left with 8,724 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PHR now has a Market Capitalization of 1459906432 and an Enterprise Value of 1032690624. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.48 while its Price-to-Book (P/B) ratio in mrq is 5.51. Its current Enterprise Value per Revenue stands at 2.46 whereas that against EBITDA is -29.145.
Stock Price History:
The Beta on a monthly basis for PHR is 0.74, which has changed by 0.13997245 over the last 52 weeks, in comparison to a change of 0.036926866 over the same period for the S&P500. Over the past 52 weeks, PHR has reached a high of $30.53, while it has fallen to a 52-week low of $17.07. The 50-Day Moving Average of the stock is -8.62%, while the 200-Day Moving Average is calculated to be 4.39%.
Shares Statistics:
PHR traded an average of 463.34K shares per day over the past three months and 500370 shares per day over the past ten days. A total of 58.73M shares are outstanding, with a floating share count of 53.78M. Insiders hold about 8.49% of the company’s shares, while institutions hold 92.97% stake in the company. Shares short for PHR as of 1741910400 were 1862405 with a Short Ratio of 4.02, compared to 1739491200 on 2499270. Therefore, it implies a Short% of Shares Outstanding of 1862405 and a Short% of Float of 3.83.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
